PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How are disease-modifying antirheumatic drugs used to treat psoriatic arthritis?

ANSWER

If your disease is more severe or doesn't respond well to nonsteroidal anti-inflammatory drugs (NSAIDs), your doctor may prescribe a disease-modifying antirheumatic drug. These can slow or stop pain, swelling, and joint and tissue damage. They're stronger than NSAIDs, and they may take longer to work.

From: Psoriatic Arthritis Treatment WebMD Medical Reference

SOURCES:

Sharon Mayo, Health Educator, National Psoriasis Foundation

Alice Gottlieb, MD, PhD, Dermatologist-in-Chief, Tufts Medical Center

National Psoriasis Foundation: “Psoriatic Arthritis” “Psoriatic Arthritis Treatments”

American College of Rheumatology: “NSAIDS: Nonsteroidal Anti-Inflammatory Drugs”

American Academy of Dermatology: “Guidelines of care for the management of psoriasis and psoriatic arthritis.”

MedLine Plus Medical Encyclopedia: “Diclofenac and misoprostol.”

Johnston, BL and Conly, JM. , July-August 2006. Canadian Journal of Infectious Diseases and Medical Microbiology

UpToDate: "Treatment of psoriatic arthritis."

Schett, G. , October 2010. Therapeutic Advances in Musculoskeletal Disease

 FDA. “FDA approves Inflectra, a biosimilar to Remicade.” “FDA approves Amjevita, a biosimilar to Humira.”

Reviewed by David Zelman on April 29, 2019

SOURCES:

Sharon Mayo, Health Educator, National Psoriasis Foundation

Alice Gottlieb, MD, PhD, Dermatologist-in-Chief, Tufts Medical Center

National Psoriasis Foundation: “Psoriatic Arthritis” “Psoriatic Arthritis Treatments”

American College of Rheumatology: “NSAIDS: Nonsteroidal Anti-Inflammatory Drugs”

American Academy of Dermatology: “Guidelines of care for the management of psoriasis and psoriatic arthritis.”

MedLine Plus Medical Encyclopedia: “Diclofenac and misoprostol.”

Johnston, BL and Conly, JM. , July-August 2006. Canadian Journal of Infectious Diseases and Medical Microbiology

UpToDate: "Treatment of psoriatic arthritis."

Schett, G. , October 2010. Therapeutic Advances in Musculoskeletal Disease

 FDA. “FDA approves Inflectra, a biosimilar to Remicade.” “FDA approves Amjevita, a biosimilar to Humira.”

Reviewed by David Zelman on April 29, 2019

NEXT QUESTION:

What disease-modifying antirheumatic drugs are commonly used to treat psoriatic arthritis?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.